SIRS is initiated and progressed by activation of complement factors (C3a, C4a, and C5a), neutrophils, and an imbalance in inflammatory/anti-inflammatory cytokines (TNF-α, IL-1, IL-2, and IL-6). The gene discussed is C3; the disease is systemic inflammatory response syndrome.